Superclop 75 Tablet
Marketer
Eris Lifesciences Ltd
Salt Composition
Clopidogrel (75mg)
Overview Superclop 75 Tablet
CardioGuard 75mg tablets are antiplatelet agents, preventing the formation of dangerous blood clots within your circulatory system. This significantly reduces the risk of stroke or myocardial infarction. A widely prescribed cardioprotective medication, CardioGuard 75mg is indicated for individuals at elevated risk of cardiovascular events. This includes those with peripheral artery disease (circulatory issues from vascular narrowing), recent stroke or heart attack, arrhythmias, and post-stenting patients. It's also used adjunctively with other medications to manage myocardial infarction and unstable angina. This medication can be administered with or without food, consistently at the same time daily. Continuous use is crucial; discontinuation increases the risk of stroke or heart attack. The most frequent adverse effect is bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wounds may bleed more profusely and for longer than usual. While typically mild and self-resolving, persistent or concerning bleeding requires immediate medical attention. This medication is contraindicated in patients with active internal bleeding, such as gastrointestinal ulcers or intracranial hemorrhage. Prior to commencement, inform your physician of any prior bleeding disorders or recent major trauma or surgery. Temporary cessation may be necessary before scheduled surgery or dental procedures.
Primary Ingredients of Superclop 75 Tablet
No text was provided to rewrite.
Uses of Superclop 75 Tablet
Cardiovascular event prophylaxis
Major Benefits of Superclop 75 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Superclop 75 Tablet. Ingest the tablet whole; avoid crushing, chewing, or breaking it. While Superclop 75 Tablet can be administered with or without food, consistent timing is recommended.
Common Side effects of Superclop 75 Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Superclop 75 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Superclop 75 Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Superclop 75 may be administered with or without food, consistent timing is recommended.
How Superclop 75 Tablet works:
ClopSeven 75mg tablets are an antithrombotic agent. Their mechanism of action inhibits platelet aggregation, reducing the risk of dangerous thrombus formation. This consequently minimizes the likelihood of cardiovascular events such as myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Using Superclop 75 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Superclop 75 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Superclop 75 Tablet use appear compatible. Preliminary human studies indicate minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Superclop 75 Tablet.
KidneySAFE IF PRESCRIBED
Superclop 75 Tablet poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Superclop 75 Tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Superclop 75 Tablet :
Should you forget a Superclop 75 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Superclop 75 Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alpha esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |



